Parallel Bio’s head of technology shares a vision for faster, cheaper, and better biological research with human organoids. Ari Gesher, Parallel Bio’s new head of technology, may be new to biotech, but that’s not stopping him from thinking big about disrupting the status quo in biological research. The biotech startup is betting on automation and…